Your browser is no longer supported. Please, upgrade your browser.
AXNX [NASD]
Axonics, Inc.
Index- P/E- EPS (ttm)-1.50 Insider Own1.40% Shs Outstand38.99M Perf Week-9.55%
Market Cap2.35B Forward P/E- EPS next Y-0.72 Insider Trans-38.07% Shs Float33.67M Perf Month-5.13%
Income-54.90M PEG- EPS next Q-0.46 Inst Own- Short Float12.50% Perf Quarter5.84%
Sales111.50M P/S21.04 EPS this Y46.90% Inst Trans0.58% Short Ratio8.16 Perf Half Y10.52%
Book/sh7.37 P/B7.72 EPS next Y57.90% ROA-21.10% Target Price68.11 Perf Year63.05%
Cash/sh5.85 P/C9.73 EPS next 5Y- ROE-25.20% 52W Range32.15 - 64.36 Perf YTD14.02%
Dividend- P/FCF- EPS past 5Y- ROI-17.40% 52W High-11.56% Beta-
Dividend %- Quick Ratio5.80 Sales past 5Y- Gross Margin60.20% 52W Low77.07% ATR2.62
Employees416 Current Ratio7.20 Sales Q/Q251.50% Oper. Margin-58.90% RSI (14)41.59 Volatility5.63% 4.30%
OptionableYes Debt/Eq0.07 EPS Q/Q61.10% Profit Margin-59.50% Rel Volume1.47 Prev Close56.00
ShortableYes LT Debt/Eq0.00 EarningsMay 06 AMC Payout- Avg Volume515.79K Price56.92
Recom1.60 SMA20-5.59% SMA50-2.25% SMA20014.43% Volume755,840 Change1.64%
Nov-05-20Reiterated Needham Buy $57 → $62
Oct-23-20Initiated Guggenheim Buy $77
Sep-02-20Initiated Robert W. Baird Outperform $52
Aug-07-20Reiterated Needham Buy $48 → $57
Jan-08-20Initiated SunTrust Buy $38
Nov-01-19Initiated Piper Jaffray Overweight $39
Oct-21-19Initiated Barclays Overweight $43
Sep-17-19Initiated SVB Leerink Outperform $45
Sep-09-19Reiterated Needham Buy $43 → $48
Sep-03-19Initiated Needham Buy $43
Jun-13-19Reiterated BofA/Merrill Buy $30 → $35
Nov-26-18Initiated Wells Fargo Outperform $22
Nov-26-18Initiated SunTrust Buy $20
Nov-26-18Initiated Morgan Stanley Overweight $21
Nov-26-18Initiated BofA/Merrill Buy $23
May-06-21 06:15PM  
04:01PM  
02:45PM  
Apr-29-21 05:03PM  
Apr-22-21 06:00AM  
Apr-15-21 06:00AM  
Apr-06-21 02:13AM  
Mar-03-21 06:00AM  
Mar-02-21 07:55AM  
06:00AM  
Feb-25-21 04:05PM  
04:01PM  
02:30PM  
Feb-24-21 10:07AM  
Feb-22-21 04:01PM  
Feb-18-21 06:00AM  
Feb-16-21 06:00AM  
Feb-11-21 06:00AM  
Feb-05-21 07:45PM  
Jan-25-21 04:01PM  
Jan-06-21 12:45AM  
Dec-14-20 08:00AM  
Nov-19-20 06:00AM  
Nov-10-20 06:00AM  
Nov-07-20 08:00AM  
07:57AM  
Nov-04-20 05:15PM  
04:00PM  
02:30PM  
Oct-29-20 06:00AM  
Oct-28-20 12:32PM  
Oct-20-20 04:20PM  
08:00AM  
Oct-14-20 10:26AM  
06:00AM  
Oct-08-20 02:48PM  
Oct-07-20 04:00PM  
Oct-05-20 07:45PM  
08:00AM  
Sep-30-20 08:31AM  
07:36AM  
Sep-29-20 02:40PM  
10:29AM  
Sep-28-20 08:54PM  
12:20PM  
09:47AM  
Sep-24-20 06:00AM  
Sep-23-20 07:00AM  
Sep-21-20 06:00AM  
Sep-16-20 09:00AM  
Sep-10-20 06:00AM  
Sep-08-20 08:30AM  
Sep-03-20 06:00AM  
Sep-02-20 10:00AM  
Aug-10-20 09:08AM  
08:53AM  
Aug-06-20 04:00PM  
Jul-30-20 12:33PM  
Jul-27-20 06:00AM  
Jul-17-20 03:31PM  
Jul-16-20 06:00AM  
Jul-13-20 06:00AM  
Jul-01-20 04:00PM  
Jun-17-20 02:04PM  
Jun-03-20 11:29AM  
06:00AM  
May-19-20 06:00AM  
03:38AM  
May-12-20 07:00PM  
04:05PM  
May-07-20 09:14PM  
04:12PM  
09:07AM  
May-05-20 06:15PM  
04:00PM  
May-04-20 06:00AM  
Apr-29-20 06:00AM  
Apr-28-20 12:34PM  
Apr-20-20 06:41AM  
Apr-14-20 06:00AM  
Apr-08-20 06:00AM  
Apr-07-20 06:00AM  
Apr-06-20 06:00AM  
Mar-25-20 10:18AM  
Mar-16-20 06:00AM  
Mar-04-20 05:15PM  
04:01PM  
02:30PM  
Feb-26-20 12:30PM  
Feb-25-20 06:00AM  
Feb-19-20 06:00AM  
Feb-11-20 06:00AM  
Feb-04-20 06:00AM  
Jan-24-20 12:14PM  
Jan-21-20 06:00AM  
Jan-15-20 05:25AM  
Jan-09-20 06:00AM  
Dec-19-19 09:51PM  
06:00AM  
Dec-12-19 06:00AM  
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dearen Danny L.See RemarksApr 21Option Exercise9.1325,000228,36535,000Apr 23 07:50 PM
Dearen Danny L.See RemarksApr 21Sale61.6325,0001,540,83310,000Apr 23 07:50 PM
Dearen Danny L.See RemarksApr 20Option Exercise1.421,2651,79685,000Apr 23 07:50 PM
Dearen Danny L.See RemarksApr 20Sale58.1575,0004,361,41910,000Apr 23 07:50 PM
Ford Alfred J JrChief Commercial OfficerApr 19Option Exercise10.1246,197467,59359,921Apr 21 09:19 PM
Ford Alfred J JrChief Commercial OfficerApr 19Sale58.5654,2963,179,4065,625Apr 21 09:19 PM
Sama RindaChief Operating OfficerApr 16Sale60.071,15269,19639,295Apr 19 09:52 PM
Sama RindaChief Operating OfficerApr 15Sale59.0673,8484,361,49340,447Apr 19 09:52 PM
Woock JohnChief Marketing OfficerFeb 25Sale50.8210,000508,19554,932Mar 02 08:15 PM
Woock JohnChief Marketing OfficerFeb 01Option Exercise0.005,334066,849Feb 01 09:49 PM
COHEN RAYMOND WChief Executive OfficerFeb 01Option Exercise0.0033,3340469,723Feb 02 08:50 PM
Dearen Danny L.See RemarksFeb 01Option Exercise0.0016,000090,993Feb 02 08:51 PM
Ford Alfred J JrChief Commercial OfficerFeb 01Option Exercise0.005,334015,607Feb 02 08:52 PM
Sama RindaChief Operating OfficerFeb 01Option Exercise0.0011,3340118,557Feb 02 08:52 PM
Sama RindaChief Operating OfficerFeb 01Sale51.424,262219,140114,295Feb 02 08:52 PM
Ford Alfred J JrChief Commercial OfficerFeb 01Sale51.421,88396,81913,724Feb 02 08:52 PM
Dearen Danny L.See RemarksFeb 01Sale51.427,258373,18683,735Feb 02 08:51 PM
COHEN RAYMOND WChief Executive OfficerFeb 01Sale51.4213,627700,661456,096Feb 02 08:50 PM
Woock JohnChief Marketing OfficerFeb 01Sale51.361,91798,46664,932Feb 01 09:49 PM
Woock JohnChief Marketing OfficerJan 28Sale53.2315,000798,42155,890Feb 01 09:49 PM
Sama RindaChief Operating OfficerJan 26Option Exercise0.009,2390100,440Jan 27 08:09 PM
Woock JohnChief Marketing OfficerJan 26Option Exercise0.005,435072,783Jan 27 08:09 PM
Ford Alfred J JrChief Commercial OfficerJan 26Option Exercise0.007,06507,065Jan 27 08:08 PM
Dearen Danny L.See RemarksJan 26Option Exercise0.0013,043069,534Jan 27 08:08 PM
COHEN RAYMOND WChief Executive OfficerJan 26Option Exercise0.0027,1730424,231Jan 27 08:08 PM
Dearen Danny L.See RemarksJan 26Sale53.584,541243,29164,993Jan 27 08:08 PM
Ford Alfred J JrChief Commercial OfficerJan 26Sale53.582,417129,4954,648Jan 27 08:08 PM
COHEN RAYMOND WChief Executive OfficerJan 26Sale53.587,842420,148416,389Jan 27 08:08 PM
Woock JohnChief Marketing OfficerJan 26Sale53.581,893101,42170,890Jan 27 08:09 PM
Sama RindaChief Operating OfficerJan 26Sale53.583,217172,35697,223Jan 27 08:09 PM
MCNAMARA ROBERT EDirectorJan 13Sale51.839,167475,1337,500Jan 15 07:12 PM
Sama RindaChief Operating OfficerDec 08Sale46.318,763405,84491,201Dec 10 08:12 PM
Woock JohnChief Marketing OfficerNov 27Option Exercise1.4210,00014,20077,348Dec 01 09:43 PM
Woock JohnChief Marketing OfficerNov 27Sale44.6710,000446,71767,348Dec 01 09:43 PM
Sama RindaChief Operating OfficerNov 25Sale43.9110,000439,14299,964Nov 30 08:19 PM
Sama RindaChief Operating OfficerNov 04Sale50.122,600130,314109,964Nov 06 06:48 PM
Sama RindaChief Operating OfficerNov 03Sale50.0030015,000112,564Nov 03 08:33 PM
Sama RindaChief Operating OfficerOct 30Sale47.927,137341,999112,864Nov 03 08:33 PM
Sama RindaChief Operating OfficerOct 29Option Exercise11.6212,863149,531132,864Nov 03 08:33 PM
Sama RindaChief Operating OfficerOct 29Sale48.0312,863617,836120,001Nov 03 08:33 PM
Tammenoms Bakker JulietDirectorSep 18Sale42.679,167391,1193,500Sep 22 06:01 PM
Ford Alfred J JrChief Commercial OfficerSep 02Option Exercise1.4235,00049,70035,000Sep 02 07:44 PM
Ford Alfred J JrChief Commercial OfficerSep 02Sale40.2435,0001,408,2300Sep 02 07:44 PM
Ford Alfred J JrChief Commercial OfficerAug 31Sale42.312,667112,8450Sep 02 07:44 PM
Woock JohnChief Marketing OfficerAug 28Option Exercise1.4810,00014,75077,348Sep 02 08:34 AM
Woock JohnChief Marketing OfficerAug 28Sale43.4510,000434,51867,348Sep 02 08:34 AM
Tammenoms Bakker JulietDirectorAug 14Sale43.222,393103,4229,167Aug 18 05:32 PM
COHEN RAYMOND WChief Executive OfficerAug 11Sale42.1525,0001,053,636397,058Aug 11 08:32 PM
COHEN RAYMOND WChief Executive OfficerAug 07Sale41.9820,000839,583422,058Aug 11 08:32 PM
Sama RindaChief Operating OfficerAug 07Sale44.0630,0001,321,730120,001Aug 10 09:26 PM
Sama RindaChief Operating OfficerAug 06Sale43.4020,000867,918150,001Aug 10 09:26 PM
Sama RindaChief Operating OfficerJul 29Sale43.001,29255,556170,001Jul 30 09:06 PM
Sama RindaChief Operating OfficerJul 28Sale43.1013,708590,860171,293Jul 30 09:06 PM
Sama RindaChief Operating OfficerJul 21Option Exercise14.1913,127186,272199,401Jul 22 09:58 PM
Sama RindaChief Operating OfficerJul 21Sale40.8114,400587,611185,001Jul 22 09:58 PM
Sama RindaChief Operating OfficerJul 20Option Exercise5.8620,600120,782206,874Jul 22 09:58 PM
Sama RindaChief Operating OfficerJul 20Sale39.3720,600811,023186,274Jul 22 09:58 PM
COHEN RAYMOND WChief Executive OfficerJul 16Sale39.6525,000991,268442,058Jul 17 07:38 PM
COHEN RAYMOND WChief Executive OfficerJul 15Sale39.2525,000981,327467,058Jul 17 07:38 PM
COHEN RAYMOND WChief Executive OfficerJul 14Sale36.4925,000912,273492,058Jul 15 09:55 PM
COHEN RAYMOND WChief Executive OfficerJul 13Sale40.3525,0001,008,761517,058Jul 15 09:55 PM
Dearen Danny L.See RemarksJul 07Option Exercise1.637091,15657,200Jul 09 06:22 PM
Dearen Danny L.See RemarksJul 07Sale40.0070928,36056,491Jul 09 06:22 PM
Dearen Danny L.See RemarksJun 22Option Exercise1.5645,00070,171101,491Jun 22 09:58 PM
Dearen Danny L.See RemarksJun 22Sale38.1145,0001,714,97756,491Jun 22 09:58 PM
Dearen Danny L.See RemarksJun 18Option Exercise1.4130,00042,37586,491Jun 22 09:58 PM
Dearen Danny L.See RemarksJun 18Sale39.2630,0001,177,88156,491Jun 22 09:58 PM
Dearen Danny L.See RemarksMay 19Option Exercise1.3215,00019,80071,491May 19 09:01 PM
Sama RindaChief Operating OfficerMay 19Sale39.0020780186,274May 21 09:34 PM
Dearen Danny L.See RemarksMay 19Sale40.0515,000600,77756,491May 19 09:01 PM
Dearen Danny L.See RemarksMay 18Option Exercise1.3215,00019,80071,491May 19 09:01 PM
Dearen Danny L.See RemarksMay 18Sale37.2615,000558,84256,491May 19 09:01 PM
Dearen Danny L.See RemarksMay 15Option Exercise1.0130,00030,32586,491May 19 09:01 PM
Dearen Danny L.See RemarksMay 15Sale35.1330,0001,053,99356,491May 19 09:01 PM
Dearen Danny L.See RemarksMay 14Option Exercise0.9820,00019,60076,491May 14 09:58 PM
Dearen Danny L.See RemarksMay 14Sale34.1920,000683,70756,491May 14 09:58 PM
Dearen Danny L.See RemarksMay 11Option Exercise0.9830,00029,40086,491May 14 09:58 PM
Dearen Danny L.See RemarksMay 11Sale34.8630,0001,045,94356,491May 14 09:58 PM